Trevena Inc. (TRVN) NASDAQ

$0.46 0 (0.30%)

Market Cap: $8.40M

As of 03/28/24 03:58 PM EDT. Market closed.

(TRVN)

Trevena Inc. (TRVN)
NASDAQ

$0.46
0 (0.30%)

Market Cap: $8.40M

As of 03/28/24 03:58 PM EDT. Market closed.

Add to Portfolio

trevena, inc. is a clinical stage biopharmaceutical company that discovers, develops, and intends to commercialize innovative therapies that use a novel approach to target g protein coupled receptors, or gpcrs. we are dedicated to providing value to patients and healthcare providers by improving patient outcomes and reducing healthcare costs. we have identified four biased ligand drug candidates: ... read more

trevena, inc. is a clinical stage biopharmaceutical company that discovers, develops, and intends to commercialize innovative therapies that use a novel approach to target g protein coupled receptors, or gpcrs. we are dedicated to providing value to patients and healthcare providers by improving patient outcomes and reducing healthcare costs. we have identified four biased ligand drug candidates: trv130, an fda-designated breakthrough therapy, is currently in phase 3 testing for the intravenous treatment of acute moderate to severe pain? trv027 was evaluated in a phase 2b study for the treatment of acute heart failure? trv734 has completed phase 1 testing for oral treatment of acute and chronic pain; and trv250 is in preclinical development for the treatment of migraine. in addition, trevena has an early stage portfolio of drug discovery programs currently in lead optimization. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Carrie Bourdow
Full Time Employees
54
CEO Compensation (Base)
$536,667
CEO Compensation (Total)
$2.81M
URL
Address
955 Chesterbrook Blvd Ste 110, Pennsylvania, Chesterbrook, 19087-5627.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Carrie Bourdow
Full Time Employees
54
CEO Compensation (Base)
$536,667
CEO Compensation (Total)
$2.81M
Address
955 Chesterbrook Blvd Ste 110, Pennsylvania, Chesterbrook, 19087-5627.
PRICE CHART FOR TREVENA INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.47
Previous Close
$0.46
Days Range
$0.44 - $0.46
52 week range
$0.41 - $3.28
Volume
140,012
Avg. Volume (30 days)
130,459
Market Cap
$8.40M
Dividend Yield
-
P/E
-
Shares Outstanding
18,321,101
Open
$0.47
Previous Close
$0.46
Days Range
$0.44 - $0.46
52 week range
$0.41 - $3.28
Volume
140,012
Avg. Volume (30 days)
130,459
Market Cap
$8.40M
Dividend Yield
-
P/E
-
Shares Outstanding
18,321,101
FINANCIAL STATEMENTS FOR TREVENA INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR TREVENA INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Drake Patricia M.SVP, Chief Commercial OfficerDec 14, 2023 Option Exercise$0.6175,00045,750108,913Dec 15, 2023, 06:57 PM
Drake Patricia M.SVP, Chief Commercial OfficerDec 14, 2023 Option Exercise$0.611,8351,119107,078Dec 15, 2023, 06:57 PM
Bourdow Carrie L.President & CEODec 14, 2023 Option Exercise$0.61470,000286,700650,046Dec 15, 2023, 06:57 PM
Bourdow Carrie L.President & CEODec 14, 2023 Option Exercise$0.617,1234,345642,923Dec 15, 2023, 06:57 PM
Shin BarrySVP, CFODec 14, 2023 Option Exercise$0.61235,000143,350312,437Dec 15, 2023, 06:57 PM
Shin BarrySVP, CFODec 14, 2023 Option Exercise$0.613,6162,206308,821Dec 15, 2023, 06:57 PM
Demitrack MarkSVP, Chief Medical OfficerDec 14, 2023 Option Exercise$0.61235,000143,350309,817Dec 15, 2023, 06:56 PM
Demitrack MarkSVP, Chief Medical OfficerDec 14, 2023 Option Exercise$0.613,5932,192306,224Dec 15, 2023, 06:56 PM
Yoder Robert TSVP, Chief Business OfficerDec 14, 2023 Option Exercise$0.61117,50071,675160,806Dec 15, 2023, 06:56 PM
Yoder Robert TSVP, Chief Business OfficerDec 14, 2023 Option Exercise$0.611,9291,177158,877Dec 15, 2023, 06:56 PM
Bourdow Carrie L.President & CEODec 02, 2023 Option Exercise$0.5912,0287,097190,731Dec 05, 2023, 05:51 PM
Yoder Robert TSVP, Chief Business OfficerDec 02, 2023 Option Exercise$0.593,1061,83345,976Dec 05, 2023, 05:50 PM
Shin BarrySVP, CFODec 02, 2023 Option Exercise$0.595,0362,97182,066Dec 05, 2023, 05:50 PM
Demitrack MarkSVP, Chief Medical OfficerDec 02, 2023 Option Exercise$0.595,2113,07479,531Dec 05, 2023, 05:49 PM
Drake Patricia M.SVP, Chief Commercial OfficerDec 02, 2023 Option Exercise$0.592,1291,25635,748Dec 05, 2023, 05:47 PM
Drake Patricia M.SVP, Chief Commercial OfficerNov 10, 2023 Option Exercise$0.5763236036,042Nov 14, 2023, 04:11 PM
Shin BarrySVP, CFOSep 14, 2023 Option Exercise$0.70725082,473Sep 18, 2023, 05:26 PM
Shin BarrySVP, CFOJun 26, 2023 Option Exercise$0.8472260682,545Jun 28, 2023, 04:17 PM
Bourdow Carrie L.President & CEODec 17, 2022 Option Exercise$1.551,3422,08092,074Dec 20, 2022, 04:33 PM
Shin BarrySVP, CFODec 17, 2022 Option Exercise$1.5541364033,267Dec 20, 2022, 04:32 PM
Yoder Robert TSVP, Chief Business OfficerDec 17, 2022 Option Exercise$1.5544368721,412Dec 20, 2022, 04:31 PM
Demitrack MarkSVP, Chief Medical OfficerDec 17, 2022 Option Exercise$1.5549777030,028Dec 20, 2022, 04:31 PM
Bourdow Carrie L.President & CEODec 02, 2022 Option Exercise$3.423,56012,17593,416Dec 06, 2022, 04:32 PM
Demitrack MarkSVP, Chief Medical OfficerDec 02, 2022 Option Exercise$3.421,1213,83430,525Dec 06, 2022, 04:28 PM
Drake Patricia M.SVP, Chief Commercial OfficerDec 02, 2022 Option Exercise$3.422941,00511,674Dec 06, 2022, 04:28 PM
Yoder Robert TSVP, Chief Business OfficerDec 02, 2022 Option Exercise$3.427532,57521,855Dec 06, 2022, 04:27 PM
Shin BarrySVP, CFODec 02, 2022 Option Exercise$3.421,1704,00133,680Dec 06, 2022, 04:27 PM
Drake Patricia M.SVP, Chief Commercial OfficerNov 10, 2022 Option Exercise$2.476321,56111,968Nov 15, 2022, 06:53 PM
Shin BarrySVP, CFOSep 14, 2022 Option Exercise$0.211,792369871,264Sep 16, 2022, 10:54 AM
Shin BarrySVP, CFOJun 28, 2022 Sale$0.4131,78513,032873,056Jun 29, 2022, 05:12 PM
Bourdow Carrie L.President & CEODec 17, 2021 Option Exercise$0.7033,54623,4822,424,403Dec 21, 2021, 04:17 PM
Demitrack MarkSVP, Chief Medical OfficerDec 17, 2021 Option Exercise$0.7012,4088,686791,172Dec 21, 2021, 04:16 PM
Yoder Robert TSVP, Chief Business OfficerDec 17, 2021 Option Exercise$0.709,7116,798565,205Dec 21, 2021, 04:11 PM
Shin BarrySVP, CFODec 17, 2021 Option Exercise$0.7014,2169,951904,841Dec 21, 2021, 04:10 PM
Demitrack MarkSVP, Chief Medical OfficerDec 06, 2021 Option Exercise$0.6530,60119,891803,580Dec 08, 2021, 04:17 PM
Yoder Robert TSVP, Chief Business OfficerDec 06, 2021 Option Exercise$0.6522,95014,917574,916Dec 08, 2021, 04:17 PM
Shin BarrySVP, CFO & CCODec 06, 2021 Option Exercise$0.6534,40822,365919,057Dec 08, 2021, 04:16 PM
Bourdow Carrie L.President & CEODec 06, 2021 Option Exercise$0.6593,56160,8152,457,949Dec 08, 2021, 04:16 PM
Bourdow Carrie L.President & CEOJun 28, 2021 Buy$1.7956,200100,5421,301,510Jun 28, 2021, 05:33 PM
Shin BarryChief Financial OfficerJun 25, 2021 Option Exercise$1.9624,63548,285535,965Jun 25, 2021, 05:49 PM
Applebaum ScottCLCO; SVP, Regulatory AffairsFeb 10, 2021 Option Exercise$2.8521,17860,357344,022Feb 12, 2021, 04:17 PM
Bourdow Carrie L.President & CEODec 07, 2020 Option Exercise$2.27151,684344,3231,245,310Dec 31, 2020, 04:52 PM
Yoder Robert TSr VP Chief Commercial OfficerDec 07, 2020 Option Exercise$2.2736,68883,282216,566Dec 09, 2020, 04:43 PM
Demitrack MarkSr. VP & Chief Medical OfficerDec 07, 2020 Option Exercise$2.2748,557110,224271,481Dec 09, 2020, 04:38 PM
Bourdow Carrie L.President & CEODec 07, 2020 Option Exercise$2.27132,934301,760792,960Dec 09, 2020, 04:37 PM
Shin BarryChief Financial OfficerDec 07, 2020 Option Exercise$2.2741,86195,024403,600Dec 09, 2020, 04:35 PM
Shin BarryChief Financial OfficerJun 25, 2020 Option Exercise$1.7223,53940,487445,461Jun 29, 2020, 07:49 PM
Yoder Robert TSr. VP, Chief Business OfficerDec 02, 2019 Option Exercise$0.696,8744,73586,254Dec 04, 2019, 05:48 PM
Demitrack MarkSr. VP & Chief Medical OfficerDec 02, 2019 Option Exercise$0.698,9826,188107,038Dec 04, 2019, 05:47 PM
Bourdow Carrie L.President and CEODec 02, 2019 Option Exercise$0.6917,80412,265268,894Dec 04, 2019, 05:46 PM
Demitrack MarkSr VP & Chief Medical OfficerJun 03, 2019 Option Exercise$1.178,98010,507116,020Jun 04, 2019, 04:53 PM
Hamill John P.VP Fin,Princ Fin&Acct OfficerJun 03, 2019 Option Exercise$1.175,5166,45482,234Jun 04, 2019, 04:52 PM
Hamill John P.VP Fin,Princ Fin&Acct OfficerMay 31, 2019 Buy$1.167,5008,70087,750Jun 04, 2019, 04:52 PM
Yoder Robert TSr. VP, Chief Business OfficerJun 03, 2019 Option Exercise$1.176,8728,04093,128Jun 04, 2019, 04:51 PM
Bourdow Carrie L.President and CEOJun 03, 2019 Option Exercise$1.1717,80220,828286,698Jun 04, 2019, 04:49 PM
GOWEN MAXINEPresident & CEOFeb 01, 2019 Buy$1.0250,00051,00054,000Feb 05, 2019, 04:59 PM
Bourdow Carrie L.President and CEOFeb 01, 2019 Option Exercise$1.0250,00051,000304,500Feb 05, 2019, 08:41 AM
MOULDER LEON O JRDirectorFeb 01, 2019 Buy$1.02100,000102,000100,000Feb 04, 2019, 09:01 AM
Habib YacoubSVP, Bus Dev & Corp PlanningMar 22, 2018 Sale$1.765,0008,8000Mar 23, 2018, 05:16 PM
GOWEN MAXINEPresident & CEOFeb 23, 2017 Option Exercise$0.68110,40375,295126,903Feb 27, 2017, 08:34 AM
Lark Michael W.Sr. VP, Research & CSOFeb 10, 2017 Option Exercise$0.6812,8158,74098,460Feb 14, 2017, 05:20 PM
Lark Michael W.Sr. VP, Research & CSOFeb 10, 2017 Sale$8.0023,699189,59274,761Feb 14, 2017, 05:20 PM
Bourdow Carrie L.SVP, Chief Commercial OfficerNov 09, 2016 Buy$4.344,00017,3604,500Nov 10, 2016, 06:12 PM
GOWEN MAXINEPresident & CEONov 07, 2016 Buy$4.1012,50051,25016,500Nov 09, 2016, 05:37 PM
Habib YacoubSVP, Bus Dev & Corp PlanningNov 07, 2016 Buy$4.125,00020,6005,000Nov 09, 2016, 05:36 PM
GOWEN MAXINEPresident & CEOMay 27, 2016 Buy$7.0814,08499,715293,109May 31, 2016, 05:34 PM
GOWEN MAXINEPresident & CEOMay 26, 2016 Buy$7.204,00028,8004,000May 31, 2016, 05:34 PM
GOWEN MAXINEPresident & CEOMay 26, 2016 Buy$7.194,00028,760279,025May 31, 2016, 05:34 PM
Soergel DavidSr. VP,Clinical Dev. & CMODec 10, 2015 Sale$10.5527,217287,1391,750Dec 11, 2015, 05:17 PM
Limongelli John MSr. VP,General Counsel & SecyDec 12, 2014 Buy$4.143,00012,42012,000Dec 15, 2014, 05:00 PM
MOULDER LEON O JRDirectorDec 09, 2014 Buy$3.9630,200119,59230,200Dec 10, 2014, 08:39 PM
MOULDER LEON O JRDirectorDec 10, 2014 Buy$4.0619,80080,38850,000Dec 10, 2014, 08:39 PM
Soergel DavidSr. VP, Clinical DevelopmentDec 10, 2014 Buy$4.001,2505,00028,967Dec 10, 2014, 08:37 PM
Soergel DavidSr. VP, Clinical DevelopmentDec 09, 2014 Buy$3.975001,98527,717Dec 10, 2014, 08:37 PM
Limongelli John MSr. VP,General Counsel & SecyDec 10, 2014 Buy$4.009,00036,0009,000Dec 10, 2014, 06:07 PM
Cuca RobertoSr. VP and CFODec 10, 2014 Buy$4.0025,000100,00025,000Dec 10, 2014, 06:05 PM
Yanni BarbaraDirectorDec 10, 2014 Buy$4.001,2505,0001,250Dec 10, 2014, 06:03 PM
DOUGHERTY MICHAEL RDirectorDec 10, 2014 Buy$4.007,00028,0007,000Dec 10, 2014, 06:01 PM
Soergel DavidSr. VP, Clinical DevelopmentDec 10, 2014 Buy$4.001,2505,00028,467Dec 10, 2014, 05:59 PM
Lark Michael W.Sr. VP, Research & CSODec 10, 2014 Buy$4.005,00020,00085,645Dec 10, 2014, 05:56 PM
GOWEN MAXINEPresident & CEODec 10, 2014 Buy$4.008,00032,000326,025Dec 10, 2014, 05:54 PM
Alta Partners VIII, L.P.10% OwnerDec 10, 2014 Buy$4.00500,0002,000,0004,390,262Dec 10, 2014, 05:51 PM
New Enterprise Associates 12, Limited Partnership10% OwnerDec 10, 2014 Buy$4.001,000,0004,000,0004,811,691Dec 10, 2014, 12:13 PM
Deegan RosamondSr VP, Bus Dev & OperationsSep 29, 2014 Sale$7.004430831,105Oct 01, 2014, 04:48 PM
Polaris Venture Management Co. V, L.L.C.10% OwnerAug 14, 2014 Sale$6.0436,702221,6803,637,115Aug 18, 2014, 04:30 PM
Polaris Venture Management Co. V, L.L.C.10% OwnerAug 13, 2014 Sale$6.125,70034,8843,672,530Aug 15, 2014, 04:30 PM
GOWEN MAXINEPresident & CEOApr 23, 2014 Option Exercise$0.68124,47784,893318,025May 15, 2014, 09:37 PM
Forest Laboratories Holdings Ltd10% OwnerFeb 05, 2014 Buy$7.00428,5712,999,9973,393,466Feb 07, 2014, 01:14 PM
New Enterprise Associates 12, Limited Partnership10% OwnerFeb 05, 2014 Buy$7.00472,4103,306,8703,811,691Feb 07, 2014, 12:16 PM
Polaris Venture Management Co. V, L.L.C.10% OwnerFeb 05, 2014 Buy$7.00472,4053,306,8353,811,682Feb 07, 2014, 12:06 PM
HealthCare Ventures VIII, L.P.10% OwnerFeb 05, 2014 Buy$7.00297,0582,079,4062,446,251Feb 07, 2014, 12:02 PM
Alta Partners VIII, L.P.10% OwnerFeb 05, 2014 Buy$7.00472,4103,306,8703,890,262Feb 07, 2014, 11:57 AM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Drake Patricia M.SVP, Chief Commercial Officer12/14/202345,750
Drake Patricia M.SVP, Chief Commercial Officer12/14/20231,119
Bourdow Carrie L.President & CEO12/14/2023286,700
Bourdow Carrie L.President & CEO12/14/20234,345
Shin BarrySVP, CFO12/14/2023143,350
Shin BarrySVP, CFO12/14/20232,206
Demitrack MarkSVP, Chief Medical Officer12/14/2023143,350
Demitrack MarkSVP, Chief Medical Officer12/14/20232,192
Yoder Robert TSVP, Chief Business Officer12/14/202371,675
Yoder Robert TSVP, Chief Business Officer12/14/20231,177
Bourdow Carrie L.President & CEO12/02/20237,097
Yoder Robert TSVP, Chief Business Officer12/02/20231,833
Shin BarrySVP, CFO12/02/20232,971
Demitrack MarkSVP, Chief Medical Officer12/02/20233,074
Drake Patricia M.SVP, Chief Commercial Officer12/02/20231,256
Drake Patricia M.SVP, Chief Commercial Officer11/10/2023360
Shin BarrySVP, CFO09/14/202350
Shin BarrySVP, CFO06/26/2023606
Bourdow Carrie L.President & CEO12/17/20222,080
Shin BarrySVP, CFO12/17/2022640
Yoder Robert TSVP, Chief Business Officer12/17/2022687
Demitrack MarkSVP, Chief Medical Officer12/17/2022770
Bourdow Carrie L.President & CEO12/02/202212,175
Demitrack MarkSVP, Chief Medical Officer12/02/20223,834
Drake Patricia M.SVP, Chief Commercial Officer12/02/20221,005
Yoder Robert TSVP, Chief Business Officer12/02/20222,575
Shin BarrySVP, CFO12/02/20224,001
Drake Patricia M.SVP, Chief Commercial Officer11/10/20221,561
Shin BarrySVP, CFO09/14/2022369
Shin BarrySVP, CFO06/28/202213,032
Bourdow Carrie L.President & CEO12/17/202123,482
Demitrack MarkSVP, Chief Medical Officer12/17/20218,686
Yoder Robert TSVP, Chief Business Officer12/17/20216,798
Shin BarrySVP, CFO12/17/20219,951
Demitrack MarkSVP, Chief Medical Officer12/06/202119,891
Yoder Robert TSVP, Chief Business Officer12/06/202114,917
Shin BarrySVP, CFO & CCO12/06/202122,365
Bourdow Carrie L.President & CEO12/06/202160,815
Bourdow Carrie L.President & CEO06/28/2021100,542
Shin BarryChief Financial Officer06/25/202148,285
Applebaum ScottCLCO; SVP, Regulatory Affairs02/10/202160,357
Bourdow Carrie L.President & CEO12/07/2020344,323
Yoder Robert TSr VP Chief Commercial Officer12/07/202083,282
Demitrack MarkSr. VP & Chief Medical Officer12/07/2020110,224
Bourdow Carrie L.President & CEO12/07/2020301,760
Shin BarryChief Financial Officer12/07/202095,024
Shin BarryChief Financial Officer06/25/202040,487
Yoder Robert TSr. VP, Chief Business Officer12/02/20194,735
Demitrack MarkSr. VP & Chief Medical Officer12/02/20196,188
Bourdow Carrie L.President and CEO12/02/201912,265
Demitrack MarkSr VP & Chief Medical Officer06/03/201910,507
Hamill John P.VP Fin,Princ Fin&Acct Officer06/03/20196,454
Hamill John P.VP Fin,Princ Fin&Acct Officer05/31/20198,700
Yoder Robert TSr. VP, Chief Business Officer06/03/20198,040
Bourdow Carrie L.President and CEO06/03/201920,828
GOWEN MAXINEPresident & CEO02/01/201951,000
Bourdow Carrie L.President and CEO02/01/201951,000
MOULDER LEON O JRDirector02/01/2019102,000
Habib YacoubSVP, Bus Dev & Corp Planning03/22/20188,800
GOWEN MAXINEPresident & CEO02/23/201775,295
Lark Michael W.Sr. VP, Research & CSO02/10/20178,740
Lark Michael W.Sr. VP, Research & CSO02/10/2017189,592
Bourdow Carrie L.SVP, Chief Commercial Officer11/09/201617,360
GOWEN MAXINEPresident & CEO11/07/201651,250
Habib YacoubSVP, Bus Dev & Corp Planning11/07/201620,600
GOWEN MAXINEPresident & CEO05/27/201699,715
GOWEN MAXINEPresident & CEO05/26/201628,800
GOWEN MAXINEPresident & CEO05/26/201628,760
Soergel DavidSr. VP,Clinical Dev. & CMO12/10/2015287,139
Limongelli John MSr. VP,General Counsel & Secy12/12/201412,420
MOULDER LEON O JRDirector12/09/2014119,592
MOULDER LEON O JRDirector12/10/201480,388
Soergel DavidSr. VP, Clinical Development12/10/20145,000
Soergel DavidSr. VP, Clinical Development12/09/20141,985
Limongelli John MSr. VP,General Counsel & Secy12/10/201436,000
Cuca RobertoSr. VP and CFO12/10/2014100,000
Yanni BarbaraDirector12/10/20145,000
DOUGHERTY MICHAEL RDirector12/10/201428,000
Soergel DavidSr. VP, Clinical Development12/10/20145,000
Lark Michael W.Sr. VP, Research & CSO12/10/201420,000
GOWEN MAXINEPresident & CEO12/10/201432,000
Alta Partners VIII, L.P.10% Owner12/10/20142,000,000
New Enterprise Associates 12, Limited Partnership10% Owner12/10/20144,000,000
Deegan RosamondSr VP, Bus Dev & Operations09/29/2014308
Polaris Venture Management Co. V, L.L.C.10% Owner08/14/2014221,680
Polaris Venture Management Co. V, L.L.C.10% Owner08/13/201434,884
GOWEN MAXINEPresident & CEO04/23/201484,893
Forest Laboratories Holdings Ltd10% Owner02/05/20142,999,997
New Enterprise Associates 12, Limited Partnership10% Owner02/05/20143,306,870
Polaris Venture Management Co. V, L.L.C.10% Owner02/05/20143,306,835
HealthCare Ventures VIII, L.P.10% Owner02/05/20142,079,406
Alta Partners VIII, L.P.10% Owner02/05/20143,306,870
Load More Insider Transactions
FUNDS WITH A POSITION IN TREVENA INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC151,5520.00017%-14.6%Other
GEODE CAPITAL MANAGEMENT, LLC115,5750.00001%29.49%Other
BLACKROCK INC.107,9290%-3.65%Other
BUYBACK ANNOUNCEMENT(S) FOR TREVENA INC
LOADING...